Skip to Main Content

Paper Details

Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.
Nat Genet
225
2017
125 variants, BRCA1, BRCA1 mutation, ER, ER-negative breast cancer, ER-negative disease, breast cancer, estrogen, estrogen receptor, estrogen-receptor, estrogen-receptor-negative breast cancer, susceptibility variants
Author NameAffiliation
Roger L Milne
Roger L MilneUniversity of Melbourne
Jonathan BeesleyQIMR Berghofer Medical Research Institute
Jonathan BeesleyQIMR Berghofer Medical Research Institute
Hilary K FinucaneHarvard T.H. Chan School of Public Health
Hilary K FinucaneMassachusetts Institute of Technology
Habibul AhsanCenter for Cancer Epidemiology and Prevention, University of Chicago
Habibul AhsanCenter for Cancer Epidemiology and Prevention, University of Chicago
Christine B AmbrosoneRoswell Park Cancer Institute
Christine B AmbrosoneRoswell Park Cancer Institute
Christopher I AmosCenter for Genomic Medicine, Geisel School of Medicine, Dartmouth College
Christopher I AmosCenter for Genomic Medicine, Geisel School of Medicine, Dartmouth College
Irene L AndrulisFred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital
Irene L AndrulisUniversity of Toronto
Irene L AndrulisFred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital
Irene L AndrulisUniversity of Toronto
Hoda Anton-CulverUniversity of California irvine
Hoda Anton-CulverUniversity of California irvine
Paul L AuerFred Hutchinson Cancer Research Center
Paul L AuerZilber School of Public Health, University of Wisconsin-Milwaukee
Javier Ben??tezSpanish National Cancer Research Centre (CNIO)
Javier Ben??tez
Javier Ben??tezSpanish National Cancer Centre (CNIO)
Leslie BernsteinBeckman Research Institute of City of Hope
William J BlotVanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine
William J BlotInternational Epidemiology Institute
Anne-Lise B??rresen-DaleInstitute for Cancer Research, Oslo University Hospital Radiumhospitalet
Anne-Lise B??rresen-DaleInstitute for Cancer Research, Oslo University Hospital Radiumhospitalet
Louise A BrintonNational Cancer Institute
Louise A BrintonNational Cancer Institute
Angela Brooks-Wilson
Angela Brooks-WilsonSimon Fraser University
Jinyoung ByunCenter for Genomic Medicine, Geisel School of Medicine, Dartmouth College
Qiuyin CaiVanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine
Ian G CampbellPeter MacCallum Cancer Centre
Ian G CampbellUniversity of Melbourne
Federico CanzianGerman Cancer Research Center (DKFZ)
Angel CarracedoGalician Foundation of Genomic Medicine, Instituto de Investigacion Sanitaria de Santiago de Compostela (IDIS), Complejo Hospitalario Universitario de Santiago
Angel CarracedoUniversidade de Santiago de Compostela
Jenny Chang-ClaudeGerman Cancer Research Center (DKFZ)
Jenny Chang-ClaudeUniversity Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf
Stephen J ChanockNational Cancer Institute
Stephen J ChanockNational Cancer Institute
Xiaoqing ChenQIMR Berghofer Medical Research Institute
Xiaoqing ChenQIMR Berghofer Medical Research Institute
Christine L ClarkeWestmead Institute for Medical Research, University of Sydney
Christine L ClarkeWestmead Institute for Medical Research, University of Sydney
David G CoxSchool of Public Health, Imperial College London
David G CoxINSERM U2, Cancer Research Center of Lyon
Kimberly F DohenyCenter for Inherited Disease Research (CIDR), Institute of Genetic Medicine, Johns Hopkins University School of Medicine
  • 1 - 50

Datasets